New ligands based on hydroxypyridinonate (HOPO) and other bidentate ligands
are explored as iron(III) sequestering agents. These are based on the N,N'
,N"-tris[(3-hydroxy-1-methyl-2-oxo-1,2-didehydropyrid-4-yl)carboxamidoethyl
]amine (TREN-Me-3,2-HOPO) platform in which one Me-3,2-HOPO ligand group is
substituted with either a 2-hydroxyisophthalamide (TREN-Me-3,2-HOPOIAM) or
a 2,3-dihydroxyterephthalamide (TREN-Me-3,2-HOPOTAM) moiety. The ferric co
mplexes have been prepared and structurally characterized by X-ray diffract
ion: Fe[TREN-Me-3,2-HOPOIAM] crystallizes in the monoclinic space group C2/
c with cell parameters a = 18.1186(3) Angstrom, b = 17.5926(2) Angstrom, c
= 25.0476(2) Angstrom, beta = 98.142(1)degrees, Z = 8. Fe[TREN-Me-3,2-HOPOT
AM](-) crystallizes in the monoclinic space group C2/c with cell parameters
a = 31.7556(12) Angstrom, b = 14.0087(6) Angstrom, c = 22.1557(9) Angstrom
, beta = 127.919(1)degrees, Z = 8. The aqueous coordination chemistry of th
ese ligands with both the ferric and ferrous redox states of iron has been
examined using spectroscopic and electrochemical methods, giving log format
ion constants of 26.89(3) (beta(110)), 31.16(6) (beta(111)) for the ferric
TREN-Me-3,2-HOPOIAM complexes and 33.89(2) (beta(110)), 38.45(2) (beta(111)
) for the ferric TREN-Me-3,2-HOPOTAM complexes. For the reduced (ferrous) c
omplexes values of 10.03(9) (beta(110)) and 13.7(2) (beta(110)) were observ
ed for the Fe[TREN-Me-3,2-HOPOIAM](-) and Fe[TREN-Me-3,2-HOPOTAM](2-) compl
exes, respectively. These data provide a complete description of metal-liga
nd speciation as a function of pH and of redox activity. The ligands descri
bed in this work are part of a new class of heteropodate ligands which expl
oit the various chelating properties of several binding units within a sing
le tripodal ligand and allow for systematic variation of the properties for
medical or other applications.